France / Français
Odd Twist in Phase 3 Alzheimer's Trial for Novel Tau Inhibitor
Although the novel tau aggregation inhibitor hydromethylthionine mesylate did not reach its coprimary endpoints, investigators insist there's more to the story ― especially...
3 hours ago - Medscape
December Education Programs Available from the Alzheimer's Association of MA/NH
Check out the following events from the Alzheimer's Association of MA/NH during the month of December, which include virtual and in-person programming geared towards...
17 hours ago - Massachusetts Healthy Aging Collaborative
Lecanemab reduces amyloid, slows cognitive decline in early Alzheimer's disease
Lecanemab reduced amyloid markers and slowed cognitive decline in patients with early Alzheimer's disease, although not without risk for adverse events, according to new data...
1 day ago - Healio - 2 articles
A New Drug Could Slow Alzheimer's Disease, Data Show
Over the past few years, Alzheimer's patients and their caregivers have been on a roller-coaster ride full of highs and lows in the search for treatments-and new research...
1 day ago - Time - 2 articles
NYC Plan for Mentally Ill Homeless; Auvelity for Alzheimer's Agitation; TikTok Harms
New York City Mayor Eric Adams announced that the city will be involuntarily hospitalizing mentally ill homeless residents who appear to be a harm to others. The once-monthly...
1 day ago - MedPageToday
Why lecanemab is the 'real deal' in the fight against Alzheimer's
Experts have hailed the lecanemab as 'beginning of the end' for Alzheimer's after the drug was found to slow cognitive decline by more than a quarter in clinical trials in...
1 day ago - Daily Mail - 2 articles
Research findings may offer a new potential therapeutic target for Alzheimer's disease
A new study links a gene concentrated in the brain's cleanup cells, known as microglia, to the inflammation that has increasingly emerged as a key mechanism contributing to...
1 day ago - News Medical - 2 articles
Alzheimer's Drug Slows Decline, Trial Data Show
Treatment with the investigational anti-amyloid agent lecanemab led to modestly less decline on cognitive and functional measures in the phase III CLARITY AD trial of early...
1 day ago - MedPageToday - 2 articles
Everything you need to know about 'breakthrough' Alzheimer's drug lecanemab
Professor John Hardy, a world-leading dementia researcher and molecular biologist at University College London, said the drug 'represents the beginning of the end'.
1 day ago - Daily Mail - 3 articles
New drug slows Alzheimer's disease, but doctors are divided over it
An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, but the research remains unclear.
1 day ago - Sydney Morning Herald
Free Registration
The headlines of Master Doctor
Statins during androgen-ablative prostate cancer therapies may offer...
In a systemic review and meta-analysis, statin therapy during androgen-ablative therapies was associated with a potential mortality benefit for men being treated for prostate...
Nomogram personalization necessary for femtosecond astigmatic correction
I developed my personal nomogram for femtosecond astigmatic incisions in cataract surgery by starting with the Nichamin-Woodcock nomogram and programming that into the...
Simple technique conserves viscoelastic
This is a simple and novel technique to efficiently and cost-effectively save an unnecessary extra viscoelastic syringe during cataract surgery. Surgeons occasionally reach the...
Odd Twist in Phase 3 Alzheimer's Trial for Novel Tau Inhibitor
Although the novel tau aggregation inhibitor hydromethylthionine mesylate did not reach its coprimary endpoints, investigators insist there's more to the story ― especially...
Parkinson's Foundation, Tag.bio partner to accelerate research, improve care...
The Parkinson's Foundation and data analytics platform Tag.bio have announced a partnership to advance research into the causes and treatment of Parkinson's disease. According...
Type, cost of nonoperative treatment for late-stage knee OA varied prior to TKA
Published results showed the type and cost of nonoperative treatment had substantial variation among patients with late-stage knee osteoarthritis prior to total knee...
The importance of early cancer screening
In this interview, Thomas Qiu, Senior Product Manager from BGI Genomics, talks to NewsMedical about current global cancer rates, and the importance of early cancer screening.
Is Surgery the Only Option for Meniscal Tear and Osteoarthritis?
New research finds that for some patients, physical therapy provides similar improvements in physical function and pain.
Privately insured, nonelderly patients face rising out-of-pocket costs for...
Increasing costs of cancer care and greater cost-sharing resulted in higher out-of-pocket costs for nonelderly, privately insured patients with breast, colorectal, lung and...
“State of Grandfamilies 2022” Report Reveals Households Led by Grandparents...
According to the “ State of Grandfamilies 2022 ” report released by Generations United, the 2.5 million children in the United States growing up in “grandfamilies” face higher...